Eyal Rubin - 23 Sep 2024 Form 4/A - Amendment Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Reporting relationship: Sr. VP and CFO
Issuer ticker: PLX
Reported as of: 23 Sep 2024
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 05 Nov 2024, 17:00:15 UTC
Original report date: 24 Sep 2024
Prior SEC filing: 17 Aug 2023
Next SEC filing: 27 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Eyal Rubin

Key filing fact

Eyal Rubin filed Form 4/A - Amendment for Protalix BioTherapeutics, Inc. (PLX) on 05 Nov 2024.

Key facts

This page summarizes Eyal Rubin's Form 4/A - Amendment filing for Protalix BioTherapeutics, Inc. (PLX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Nov 2024, 17:00.

Change

Previous filing in this sequence was filed on 17 Aug 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PLX transaction

Common Stock

Award

Transaction value
Shares: +90,909
Change %: +16%
Price
Shares after: 660,909
Date: 23 Sep 2024
Ownership: By Trust
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The original Form 4, filed on September 24, 2024, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the amount of restricted shares granted.

Footnote F2

Represents fully-vested restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the Reporting Person under the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended.

Footnote F3

To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.